Stocks in Play: Doseology Sciences Inc
Thursday, July 17, 20251:41 PM EST - Doseology Sciences Inc : Announces the appointment of Patrick W. Sills as Strategic Go-to-Market Advisor. Mr. Sills is an experienced commercial strategist with over 15 years of leadership in the nicotine and functional CPG sectors. His career includes senior roles with Philip Morris International and Fontem Ventures B.V., where he led initiatives in go-to-market strategy, product commercialization, and regulatory compliance within the nicotine pouch and reduced-risk product categories. Mr. Sills will support Doseology’s commercialization strategy, focusing on product positioning, distribution, regulatory considerations, and market expansion opportunities within the Company's oral stimulant portfolio. Doseology Sciences Inc (C.MOOD) shares were up one cent at 1.5.Stocks in Play: Doseology Sciences Inc, Fri, 18 Jul 2025 03:57:06 EST
Recent Posts

Romanian Inflation Ends Tumultuous Year in Politics Close to 10%

UK Boosts Support For Offshore Wind in Bumper Auction

Ireland Is Trying to Get Back on the Data Center Bandwagon

Notice Concerning Change of Representative Executive Officer

Polish Recycler Bets Millions on Europe’s Critical Metals Push

Blistering Metals Rally Sends Silver, Tin and Copper to Records

Wellington Management Appoints Alex Behm to Strengthen Secondaries Capabilities

TCS and AMD Announce Strategic Collaboration to Drive AI Adoption at Scale

New data reinforces Ipsen’s commitment to bringing solutions and addressing care gaps in neurological diseases at TOXINS

TOXINS 2026: Clinical Updates on Galderma’s Leading Neuromodulator Portfolio Further Reinforce Its Leadership in Injectable Aesthetics


